β-Amyloid (13-27) is a peptide fragment derived from the amyloid precursor protein, specifically representing amino acids 13 to 27 of the β-amyloid peptide. This fragment is of significant interest in Alzheimer's disease research, as it plays a role in the aggregation process that leads to amyloid plaque formation in the brains of affected individuals. The peptide is characterized by its hydrophobic nature, which contributes to its propensity to aggregate and form fibrils. It is typically synthesized through solid-phase peptide synthesis and can be analyzed using techniques such as mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy to confirm its structure and purity. The CAS number 148270-13-7 uniquely identifies this specific peptide, facilitating its recognition in scientific literature and databases. Research on β-Amyloid (13-27) focuses on understanding its biological activity, interactions with other proteins, and its potential as a target for therapeutic intervention in neurodegenerative diseases.

β-Amyloid (13-27)

148270-13-7: β-Amyloid (13-27) is a peptide fragment derived from the amyloid precursor protein, specifically representing amino acids 13 to 27 of the β-amyloid peptide. This fragment is of significant interest in Alzheimer's disease research, as it plays a role in the aggregation process that leads to amyloid plaque formation in the brains of affected individuals. The peptide is characterized by its hydrophobic nature, which contributes to its propensity to aggregate and form fibrils. It is typically synthesized through solid-phase peptide synthesis and can be analyzed using techniques such as mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy to confirm its structure and purity. The CAS number 148270-13-7 uniquely identifies this specific peptide, facilitating its recognition in scientific literature and databases. Research on β-Amyloid (13-27) focuses on understanding its biological activity, interactions with other proteins, and its potential as a target for therapeutic intervention in neurodegenerative diseases.

β-Amyloid (13-27) is a peptide consisting of amino acid of 13 to 27 of beta amyloid protein.

CAS 148270-13-7

β-Amyloid (13-27)

β-Amyloid (13-27)

Ref: TM-TP1692